PJ
Pierce James Andrew
Président de Groupe
OtherM
Insider track record
CEOAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Pierce James Andrew, Président de Groupe. Insider active across 2 companies, notably STRYKER CORP. Aggregated, 24 reports have been recorded. Activity tracked since 3 December 2021. The latest transaction was filed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations24 total
9,330 shares0Common StockSEC:0001886518-26-000007:0
430 shares0Common StockSEC:0001886518-26-000004:0
14,912 shares0Common StockSEC:0001886518-26-000003:0
2,771 shares0Common StockSEC:0001886518-26-000002:0
13,840 shares@ US$96.6435.4% of flowCommon StockSEC:0001886518-26-000001:0
211 shares0Common StockSEC:0001886518-25-000004:0
9,155 shares0Common StockSEC:0001628280-25-035071:0
314 shares0Common StockSEC:0000310764-25-000060:0
12,916 shares0Common StockSEC:0000310764-25-000037:0
9,455 shares@ US$93.0639.4% of flowCommon StockSEC:0000310764-25-000006:0
198 shares0Common StockSEC:0000310764-24-000123:0
641 shares@ US$361.269.8% of flowCommon StockSEC:0000310764-24-000106:0
203 shares0Common StockSEC:0000310764-24-000041:0
8,499 shares0Common StockSEC:0000310764-24-000027:0
10,230 shares@ US$81.1435.4% of flowCommon StockSEC:0000310764-24-000002:0
262 shares0Common StockSEC:0000310764-23-000128:0
627 shares@ US$273.277.6% of flowCommon StockSEC:0000310764-23-000109:0
107 shares0Common StockSEC:0000310764-23-000045:0
3,827 shares0Common StockSEC:0000310764-23-000036:0
262 shares0Common StockSEC:0000310764-23-000010:0
1,264 shares0Common StockSEC:0000310764-22-000097:0
765 shares0Common StockSEC:0000310764-22-000093:0
5,168 shares0Common StockSEC:0000310764-22-000053:0
1,765 shares@ US$53.600.0001% mcap50.0% of flowCommon StockSEC:0000310764-21-000154:0
About Pierce James Andrew
Pierce James Andrew is the Group President at STRYKER CORP. In this role, he oversees multiple divisions of the company, ensuring strategic alignment and operational efficiency. James brings valuable expertise in the medical sector, contributing to innovation and continuous improvement of products and services.